Herpes zoster infection, vaccination and immunocompromised rheumatology patients.
Affiliation
Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. mortimeroconnor@gmail.comIssue Date
2013-01MeSH
Antirheumatic AgentsChickenpox
Chickenpox Vaccine
Humans
Immunocompromised Host
Immunosuppressive Agents
Rheumatic Diseases
Virus Activation
Metadata
Show full item recordCitation
Herpes zoster infection, vaccination and immunocompromised rheumatology patients. 2013, 33 (1):239-40 Rheumatol. Int.Journal
Rheumatology internationalDOI
10.1007/s00296-011-2155-9PubMed ID
21947348Abstract
Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.Item Type
ArticleLanguage
enISSN
1437-160Xae974a485f413a2113503eed53cd6c53
10.1007/s00296-011-2155-9
Scopus Count
Collections
Related articles
- Herpes zoster and the search for an effective vaccine.
- Authors: Arnold N, Messaoudi I
- Issue date: 2017 Jan
- Varicella vaccination in the immunocompromised.
- Authors: Malaiya R, Patel S, Snowden N, Leventis P
- Issue date: 2015 Apr
- Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
- Authors: Leuvenink R, Aeschlimann F, Baer W, Berthet G, Cannizzaro E, Hofer M, Kaiser D, Schroeder S, Heininger U, Woerner A
- Issue date: 2016 Jun 2
- Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
- Authors: Speth F, Hinze CH, Andel S, Mertens T, Haas JP
- Issue date: 2018 Mar 2
- Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
- Authors: Freer G, Pistello M
- Issue date: 2018 Apr